Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 10, 2011, Pages

  Gill, Dipender ^a   Derry, Sheena ^a   Wiffen, Philip J ^a   Moore, R Andrew ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VALPROATE SEMISODIUM; VALPROIC ACID; ANALGESIC AGENT;

ANALGESIC ACTIVITY; DIABETIC NEUROPATHY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FIBROMYALGIA; HUMAN; NAUSEA; NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; TOXIC HEPATITIS; TREATMENT DURATION; ADULT; META ANALYSIS;

ADULT; ANALGESICS; DIABETIC NEUROPATHIES; FIBROMYALGIA; HUMANS; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VALPROIC ACID;

EID: 80155160470     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009183.pub2     Document Type: Review

References (46)

1. Agrawal RP, Goswami J, Jain S, Kochar DK. Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Research and Clinical Practice 2009;83(3):371-8. [DOI: 10.1016/j.diabres.2008.12.018]
2. Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, et al.Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM: Journal of the Association of Physicians 2004;97(1):33-8. [DOI: 10.1093/qjmed/hch007]
3. Kochar DK, Garg P, Bumb RA, Kochar SK, Mehta RD, Beniwal R, et al.Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM: Journal of the Association of Physicians 2005;98(1):29-34. [DOI: 10.1093/qjmed/hci005]
4. Drewes AM, Andreasen A, Poulsen LH. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia 1994;32(8):565-9.
5. Hardy JR, Rees EA, Gwilliam B, Ling J, Broadley K, A'Hern R. A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. Journal of Pain and Symptom Management 2001;21(3):204-9.
6. Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurologica Scandinavica 2002;106(5):248-52.
7. Otto M, Bach FW, Jensen TS, Sindrup SH. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology 2004;62(2):285-8.
8. American Academy of Neurology. Treatment of painful diabetic neuropathy. www.aan.com/globals/axon/assets/8400.pdf [accessed 5 August 2011].
9. Attal N, Cruccu G, Haanpää M, Hansson P, Jensen TS, Nurmikko T, et al.EFNS guidelines on pharmacological treatment of neuropathic pain. European Journal of Neurology 2006;13(11):1153-69. [DOI: 10.1111/j.1468-1331.2006.01511.x]
10. Backonja MM. Use of anticonvulsants for treatment of neuropathic pain. Neurology 2002;59(5 (Suppl 2)):S14-7.
11. Collins SL, Moore RA, McQuayHJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management 2000;20(6):449-58.
12. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21. [DOI: 10.1016/j.jpain.2007.09.005]
13. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, et al.Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings 2010;85(3 Suppl):S3-14. [DOI: 10.4065/%E2%80%8Bmcp.2009.0649]
14. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2006;118(3):289-305. [DOI: 10.1016/j.pain.2005.08.013]
15. Gerstner T, Bell N, König S. Oral valproic acid for epilepsy - long-term experience in therapy and side effects. Expert Opinion in Pharmacotherapy 2008;9(2):285-92. [DOI: 10.1517/14656566.9.2.285]
16. Gustorff B, Dorner T, Likar R, Grisold W, Lawrence K, Schwarz F, et al.Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiologica Scandinavica 2008;52(1):132-6.
17. Hall GC, Carroll D, Parry D, McQuay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Epidemiology and treatment of neuropathic pain: the UK primary care perspective 2006;122(1-2):156-62. [DOI: 10.1016/j.pain.2006.01.030]
18. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, Rice AS, et al.A new definition of neuropathic pain. Pain 2011;[E pub July 14].
19. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
20. Kluger BM, Meador KJ. Teratogenicity of antiepileptic medications. Seminars in Neurolology 2008;28(3):328-35. [DOI: 10.1055/s-2008-1079337]
21. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine 1987;107:224-33.
22. Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007115.pub2]
23. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311(7012):1047-52.
24. McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998. [ISBN: 0-19-263048-2]
25. McQuay HJ, Smith LA, Moore RA. Chronic pain. In: Stevens A, Raferty J, Mant J, Simpson S editor(s). Health Care Needs Assessment. Oxford: Radcliffe Publishing Ltd, 2007:519-600. [ISBN: 978-1-84619-063-6]
26. Moore RA, Gavaghan D, Tramèr MR, Collins SL, McQuay HJ. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain 1998;78(3):209-16. [DOI: 10.1016/S0304-3959(98)00140-7]
27. Moore RA, Edwards JE, McQuay HJ. Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain 2005;116(3):322-31. [DOI: 10.1016/j.pain.2005.05.001]
28. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15-24. [ISBN: 978-0-931092-69-5]
29. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD007076]
30. Moore RA, Moore OA, Derry S, Peloso PM, Gammaitoni AR, Wang H. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Annals of the Rheumatic Diseases 2010;69(2):374-9. [DOI: 10.1136/ard.2009.107805]
31. Moore RA, Straube S, Paine J, Phillips CJ, Derry S, McQuay HJ. Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain. Pain 2010;149(2):360-4. [DOI: 10.1016/j.pain.2010.02.039]
32. Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, McQuay H, ACTINPAIN Writing Group of the IASP Special Interest Group on Systematic Reviews in Pain Relief, Cochrane Pain, Palliative and Supportive Care Systematic Review Group Editors. "Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9. [DOI: doi:10.1016/j.pain.2010.05.011]
33. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD007938.pub2]
34. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al.Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Research and Management 2007;12(1):13-21.
35. National Institute for Health and Clinical Excellence. Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. www.nice.org.uk/guidance/CG96 2010.
36. Nüesch E, Trelle S, Reichenbach S, Rutjes AW, Tschannen B, Altman DG, et al.Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515. [DOI: 10.1136/bmj.c3515]
37. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD005454.pub2]
38. Straube S, Derry S, McQuay HJ, Moore RA. Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review. British Journal Clinical Pharmacology 2008;66(2):266-75. [DOI: 10.1111/j.1365-2125.2008.03200.x]
39. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurology 2008;8:29. [DOI: 10.1186/1471-2377-8-29]
40. Toth M. The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate. Medical Hypotheses 2005;64(2):267-72. [DOI: 10.1016/j.mehy.2004.07.019]
41. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD001133.pub2]
42. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD005451.pub2]
43. Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD006044.pub3]
44. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al.The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990;33:160-72.
45. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al.The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care and Research 2010;62:600-10. [DOI: 10.1002/acr.20140]
46. Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007;335(7610):87. [DOI: 10.1136/bmj.39213.565972.AE]